-
公开(公告)号:US5559143A
公开(公告)日:1996-09-24
申请号:US319916
申请日:1994-10-07
IPC分类号: A61K31/335 , A61K31/357 , A61K31/40 , A61K31/403 , A61K31/404 , A61P9/12 , A61P25/04 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07D209/14 , C07D209/46 , C07D319/20 , A61K31/405
CPC分类号: C07D209/14 , C07D209/46 , C07D319/20
摘要: The present invention is directed to a new class of serotonin 5HT.sub.1A agonists.
摘要翻译: 本发明涉及一类新的5-羟色胺5HT1A激动剂。
-
公开(公告)号:US5489579A
公开(公告)日:1996-02-06
申请号:US191996
申请日:1994-02-04
申请人: Ian A. McDonald , Bruce M. Baron
发明人: Ian A. McDonald , Bruce M. Baron
IPC分类号: A61K31/06 , A61K31/19 , A61K31/40 , A61K31/405 , A61K31/445 , A61K31/66 , A61K31/675 , A61P25/00 , A61P25/04 , A61P25/08 , A61P25/20 , A61P25/28 , A61P43/00 , A61K31/60 , A61K31/62
CPC分类号: A61K31/405 , A61K31/40 , A61K31/66 , A61K31/675
摘要: The present invention is directed to a method for poteniating the therapeutic effects of selected NMDA antagonists.
摘要翻译: 本发明涉及一种用于降低所选择的NMDA拮抗剂的治疗效果的方法。
-
公开(公告)号:US5470870A
公开(公告)日:1995-11-28
申请号:US261609
申请日:1994-06-17
申请人: Michael G. Palfreyman , Ian A. McDonald , Francesco G. Salituro , Robert Schwarcz , Bruce M. Baron
发明人: Michael G. Palfreyman , Ian A. McDonald , Francesco G. Salituro , Robert Schwarcz , Bruce M. Baron
IPC分类号: C07C229/42 , C07D209/20 , A61K31/405 , A61K31/18
CPC分类号: C07C229/42 , C07D209/20
摘要: The present invention is directed to a class of 4,6-disubstituted tryptophan derivatives, 4,6-disubstituted kynurenines, their use as NMDA antagonists and to pharmaceutical compositions containing these compounds.
摘要翻译: 本发明涉及一类4,6-二取代色氨酸衍生物,4,6-二取代的犬尿苷,它们作为NMDA拮抗剂的用途和含有这些化合物的药物组合物。
-
公开(公告)号:US5441963A
公开(公告)日:1995-08-15
申请号:US987091
申请日:1992-12-07
申请人: Ian A. McDonald , Bruce M. Baron
发明人: Ian A. McDonald , Bruce M. Baron
CPC分类号: A61K31/47
摘要: The present invention is directed to a composition and method for poteniating the therapeutic effects of a class of known NMDA antagonists.
摘要翻译: 本发明涉及用于降低一类已知NMDA拮抗剂的治疗效果的组合物和方法。
-
公开(公告)号:US5360814A
公开(公告)日:1994-11-01
申请号:US187353
申请日:1994-01-25
申请人: Michael G. Palfreyman , Ian A. McDonald , Francesco G. Salituro , Robert Schwarcz , Bruce M. Baron
发明人: Michael G. Palfreyman , Ian A. McDonald , Francesco G. Salituro , Robert Schwarcz , Bruce M. Baron
IPC分类号: C07C229/42 , C07D209/20 , A61K31/405
CPC分类号: C07C229/42 , C07D209/20
摘要: The present invention is directed to a class of 4,6-disubstituted tryptophan derivatives, 4,6-disubstituted kynurenines, their use as NMDA antagonists and to pharmaceutical compositions containing these compounds.
摘要翻译: 本发明涉及一类4,6-二取代色氨酸衍生物,4,6-二取代的犬尿苷,它们作为NMDA拮抗剂的用途和含有这些化合物的药物组合物。
-
公开(公告)号:US5318992A
公开(公告)日:1994-06-07
申请号:US91082
申请日:1993-07-13
IPC分类号: A61K38/00 , C07C243/36 , C07C271/24 , C07C279/14 , C07C281/02 , C07C281/06 , C07C281/16 , C07K5/068 , A61K31/195 , A61K31/22
CPC分类号: C07K5/06086 , C07C243/36 , C07C271/24 , C07C279/14 , C07C281/02 , C07C281/06 , C07C281/16 , A61K38/00 , C07C2101/02 , Y10S514/921
摘要: The present invention is a method of treating hypotension and shock using select ornithine or N.sup.G -arginine derivatives.
摘要翻译: 本发明是使用选择性鸟氨酸或NG-精氨酸衍生物治疗低血压和休克的方法。
-
公开(公告)号:US4943593A
公开(公告)日:1990-07-24
申请号:US409195
申请日:1989-09-19
IPC分类号: A61K31/13 , A61K31/135 , A61K31/34 , A61K31/38 , A61K31/40 , A61K31/445 , C07C217/62
CPC分类号: A61K31/40 , A61K31/13 , A61K31/135 , A61K31/34 , A61K31/38 , A61K31/445 , C07C217/62
摘要: This invention relates to certain inhibitors of lysyl oxidase and their use in the treatment of diseases and conditions associated with the abnormal deposition of collagen.
摘要翻译: 本发明涉及某些赖氨酰氧化酶抑制剂及其用于治疗与胶原异常沉积相关的疾病和病症。
-
公开(公告)号:US4650907A
公开(公告)日:1987-03-17
申请号:US805506
申请日:1985-12-05
IPC分类号: C07C211/24 , A61K20060101 , A61K31/13 , C07C20060101 , C07C47/04 , C07C209/62 , C07C211/21 , C07C217/46 , C07C317/18 , C07C317/26 , C07C317/28 , C07C323/11 , C07C323/12 , C07C323/23 , C07C323/27 , C07F13/00 , C07C87/24
CPC分类号: C07C317/28 , C07C211/24 , C07C217/46
摘要: Novel nonaromatic fluoroallylamines are potent MAO inhibitors and at low dose selectively inhibit MAO-B. They are useful in the treatment of depression and coadministered with L-dopa, in the treatment of Parkinsonism.
摘要翻译: 新型非芳族氟烯丙胺是有效的MAO抑制剂,低剂量选择性抑制MAO-B。 它们可用于治疗抑郁症并与左旋多巴共同施用,用于治疗帕金森综合症。
-
公开(公告)号:US4421767A
公开(公告)日:1983-12-20
申请号:US417751
申请日:1982-09-13
IPC分类号: A61K31/195 , C07C45/63 , C07C45/67 , C07D309/12 , C07C101/77 , A61K31/24 , C07C101/72
CPC分类号: C07D309/12 , A61K31/195 , C07C45/63 , C07C45/673
摘要: Compounds of the formula: ##STR1## wherein: X is fluorine, chlorine, or bromine;R is the group R.sub.2 as defined below;R.sub.1 is a group of the formula: ##STR2## or the group R.sub.2 as defined below; wherein R.sub.2 is: ##STR3## wherein R.sub.3 is hydrogen, (C.sub.1 -C.sub.4)alkyl, or (C.sub.1 -C.sub.4)alkoxy, andR.sub.4 is (C.sub.1 -C.sub.4)alkyl or (C.sub.1 -C.sub.4)alkoxy;or a (C.sub.1 -C.sub.8)alkyl ester thereof; or a non-toxic pharmaceutically acceptable salt thereof, inhibit MAO in vivo and can be administered either alone or in combination with an aromatic L-amino acid decarboxylase inhibitor for the treatment of depression.
摘要翻译: 下式的化合物:其中:X是氟,氯或溴; R是如下定义的基团R2; R1是下式定义的一组:
或R2; 其中R 2是氢,(C 1 -C 4)烷基或(C 1 -C 4)烷氧基,且R 4是(C 1 -C 4)烷基,(C 1 -C 4) C4)烷基或(C1-C4)烷氧基; 或其(C1-C8)烷基酯; 或其无毒的药学上可接受的盐在体内抑制MAO,并且可以单独或与芳族L-氨基酸脱羧酶抑制剂组合施用以治疗抑郁症。 -
公开(公告)号:US4413012A
公开(公告)日:1983-11-01
申请号:US382264
申请日:1982-05-26
IPC分类号: A61K31/195 , C07D309/12 , A61K31/15 , A61K31/24
CPC分类号: A61K31/195 , C07D309/12
摘要: 2-Amino-3-(3'-hydroxyphenyl)-3-butenoic acid or 2-amino-3-(3', 4'-dihydroxyphenyl)-3-butenoic acid can be used to treat depression either alone or in combination with an extracerebrally acting AADC inhibitor.
摘要翻译: 2-氨基-3-(3'-羟基苯基)-3-丁烯酸或2-氨基-3-(3',4'-二羟基苯基)-3-丁烯酸可以单独使用或与 一种肌内作用的AADC抑制剂。
-
-
-
-
-
-
-
-
-